Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing G-CSF plus Decitabine with BU-CY conditioning versus BU-CY alone for RAEB-1/RAEB-2 and AML secondary to MDS in allogeneic HSCT; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BU-CY conditioning
  • G-CSF + Decitabine + BU-CY conditioning

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: COMPLETED